Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


2 Am J Hematol
2 Ann Hematol
1 Biochem Biophys Res Commun
2 Blood
1 Cancer
1 Exp Hematol
2 J Clin Oncol
5 Leuk Lymphoma
1 Leuk Res
1 Leukemia
1 N Engl J Med
2 Oncol Rep

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Hematol

  1. PICIOCCHI A, Messina M, Elia L, Vitale A, et al
    Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage Acute Lymphoblastic Leukemia patients treated in GIMEMA clinical trials since 1996.
    Am J Hematol. 2021 May 28. doi: 10.1002/ajh.26253.

  2. ST MARTIN EC, Ferrer A, Wudhikarn K, Mangaonkar A, et al
    Clinical features and survival outcomes in patients with chronic myelomonocytic leukemia arising in the context of germline predisposition syndromes.
    Am J Hematol. 2021 May 24. doi: 10.1002/ajh.26250.

    Ann Hematol

  3. LARIBI K, Sobh M, Ghez D, Baugier de Materre A, et al
    Impact of age, functional status, and comorbidities on quality of life and outcomes in elderly patients with AML: review.
    Ann Hematol. 2021;100:1359-1376.
    PubMed         Abstract available

  4. ZENG Z, Ly C, Daver N, Cortes J, et al
    High-throughput proteomic profiling reveals mechanisms of action of AMG925, a dual FLT3-CDK4/6 kinase inhibitor targeting AML and AML stem/progenitor cells.
    Ann Hematol. 2021;100:1485-1496.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  5. ZHU S, Liu J, Kang R, Yang M, et al
    Targeting NF-kappaB-dependent alkaliptosis for the treatment of venetoclax-resistant acute myeloid leukemia cells.
    Biochem Biophys Res Commun. 2021;562:55-61.
    PubMed         Abstract available


  6. ZHAO Y, Aldoss I, Qu C, Crawford JC, et al
    Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL.
    Blood. 2021;137:471-484.
    PubMed         Abstract available

  7. COHEN AUBART F, Roos-Weil D, Armand M, Marceau-Renaut A, et al
    High frequency of clonal hematopoiesis in Erdheim-Chester disease.
    Blood. 2021;137:485-492.
    PubMed         Abstract available


  8. NGUYEN HTK, Terao MA, Green DM, Pui CH, et al
    Testicular involvement of acute lymphoblastic leukemia in children and adolescents: Diagnosis, biology, and management.
    Cancer. 2021 May 25. doi: 10.1002/cncr.33609.
    PubMed         Abstract available

    Exp Hematol

  9. GRANDITS AM, Wieser R
    Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A.
    Exp Hematol. 2021 May 21. pii: S0301-472X(21)00195.
    PubMed         Abstract available

    J Clin Oncol

  10. DINARDO CD, Lachowiez CA, Takahashi K, Loghavi S, et al
    Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia.
    J Clin Oncol. 2021 May 27:JCO2003736. doi: 10.1200/JCO.20.03736.
    PubMed         Abstract available

  11. SHORT NJ, Tallman MS, Pollyea DA, Ravandi F, et al
    Optimizing Risk Stratification in Acute Myeloid Leukemia: Dynamic Models for a Dynamic Therapeutic Landscape.
    J Clin Oncol. 2021 May 27:JCO2100067. doi: 10.1200/JCO.21.00067.

    Leuk Lymphoma

  12. BAZINET A, Rys RN, Barry A, Greenwood CMT, et al
    A 10-color flow cytometry panel for diagnosis and minimal residual disease in chronic lymphocytic leukemia.
    Leuk Lymphoma. 2021 May 21:1-8. doi: 10.1080/10428194.2021.1919658.
    PubMed         Abstract available

  13. JIN H, Zhu Y, Hong M, Wu Y, et al
    Co-occurrence of KIT and NRAS mutations defines an adverse prognostic core-binding factor acute myeloid leukemia.
    Leuk Lymphoma. 2021 May 24:1-10. doi: 10.1080/10428194.2021.1919660.
    PubMed         Abstract available

  14. SHARMA P, Rana S, Virk H, Sachdeva MUS, et al
    The frequency, hematological characteristics, and end-of induction residual disease in B-acute lymphoblastic leukemia with BCR-ABL1-like chimeric gene fusions in a high-risk cohort from India.
    Leuk Lymphoma. 2021 May 24:1-5. doi: 10.1080/10428194.2021.1929964.

  15. CUMBO C, Tota G, De Grassi A, Anelli L, et al
    RUNX1 gene alterations characterized by allelic preference in adult acute myeloid leukemia.
    Leuk Lymphoma. 2021 May 24:1-5. doi: 10.1080/10428194.2021.1929960.

  16. YURKIEWICZ IR, Coutre S, Ghesquieres H, Pastan I, et al
    Moxetumomab pasudotox as re-treatment for heavily-pretreated relapsed hairy cell leukemia.
    Leuk Lymphoma. 2021 May 25:1-3. doi: 10.1080/10428194.2021.1929959.

    Leuk Res

  17. TANG Z, Kanagal-Shamanna R, Tang G, Patel K, et al
    Analytical and clinical performance of chromosomal microarrays compared with FISH panel and conventional karyotyping in patients with chronic lymphocytic leukemia.
    Leuk Res. 2021;108:106616.
    PubMed         Abstract available


  18. SAYGIN C, Hu E, Zhang P, Sher S, et al
    Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq.
    Leukemia. 2021 May 21. pii: 10.1038/s41375-021-01295.
    PubMed         Abstract available

    N Engl J Med

  19. MARKEWITZ RDH, Dargvainiene J
    Mitotic and Apoptotic Figures on a Peripheral-Blood Smear.
    N Engl J Med. 2021;384:1942.

    Oncol Rep

  20. SHI YF, Huang ZY, Huang YS, Dong RJ, et al
    Interaction between CD9 and PI3Kp85 activates the PI3K/AKT signaling pathway in Blineage acute lymphoblastic leukemia.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

  21. LIU YH, Zhu M, Lei PP, Pan XY, et al
    ND09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCRABL signaling.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.